BusinessTilray Brands Sees 5% Boost in Q2 Cannabis Revenue
Tilray Brands reports a 5% growth in Q2 revenue, driven by international and Canadian sales.
Jan 9, 2026
Read
Medical Cannabis Editor
Dr. Maya Patel is a licensed pharmacist and cannabis therapeutics specialist with a Doctor of Pharmacy degree from UC San Francisco. Before joining MunchNews, she spent eight years in clinical pharmacy and cannabis research, publishing peer-reviewed studies on cannabinoid interactions. Maya translates complex medical research into accessible content, helping readers understand the science behind cannabis medicine. She serves on the editorial board of the Journal of Cannabis Research.
BusinessTilray Brands reports a 5% growth in Q2 revenue, driven by international and Canadian sales.
Cannabis Hyperemesis Syndrome (CHS), linked to chronic cannabis use, now has a WHO medical code, aiding global research.